FR2706770A1 - Formula for the treatment of tuberculosis. - Google Patents

Formula for the treatment of tuberculosis. Download PDF

Info

Publication number
FR2706770A1
FR2706770A1 FR9307804A FR9307804A FR2706770A1 FR 2706770 A1 FR2706770 A1 FR 2706770A1 FR 9307804 A FR9307804 A FR 9307804A FR 9307804 A FR9307804 A FR 9307804A FR 2706770 A1 FR2706770 A1 FR 2706770A1
Authority
FR
France
Prior art keywords
tuberculosis
essential oils
formula
treatment
caryophylata
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9307804A
Other languages
French (fr)
Other versions
FR2706770B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9307804A priority Critical patent/FR2706770A1/en
Publication of FR2706770A1 publication Critical patent/FR2706770A1/en
Application granted granted Critical
Publication of FR2706770B1 publication Critical patent/FR2706770B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention consists of a mixture of essential oils, the synergy of which has a decisive action on the bacillus responsible for tuberculosis. The formula for the treatment of tuberculosis is composed of the following essential oils: Eucalyptus globus, Melaleuca leucadendron, Thymus vulgaris, Humulus lupulus, Eugenia caryophylata, Mentha piperita and Origanum vulgare.

Description

LA PRESENTE INVENTION CONCERNE LA DECOUVERTE D'UNE FORMULE POUR TRAITER
LA TUBERCULOSE.THIS INVENTION CONCERNS THE DISCOVERY OF A TREATMENT FORMULA
TUBERCULOSIS.

CETTE PATHOLOGIE QUI AVAIT PRATIQUEMENT DISPARUE, REFAIT SA REAPPARITION
UN PEU PARTOUT DANS LE MONDE ET, COMME ON A PU LE CONSTATER, DANS LES
PAYS OU LES HABITANTS SONT SOUS-ALIMENTES: SOMALIE, ETHIOPIE, MAIS AUSSI
DANS LES ETATS SOUMIS A D'AUTRES FLEAUX COMME LA DROGUE ET LE SIDA.THIS PATHOLOGY, WHICH HAD NEARLY DISAPPEARED, IS RE-APPEARING
A LITTLE EVERYWHERE IN THE WORLD AND, AS WE HAVE BEEN TO NOTE, IN THE
COUNTRIES WHERE PEOPLE ARE UNDERNOURISHED: SOMALIA, ETHIOPIA, BUT ALSO
IN STATES SUBJECT TO OTHER FLOWERS SUCH AS DRUGS AND AIDS.

UNE RECRUDESCENCE DE CETTE MALADIE EST DONC CONSTATEE ET IMPOSE DE METTRE
LE PLUS VITE POSSIBLE, A LA DISPOSITION D'UN LABORATOIRE DE FABRICATION,
UNE FORMULE CONTRE LE BACILLE DE KOCH A BASE DE PRODUITS NATURELS,SANS
RISQUES D'EFFETS IATROGENES.A RECRUDESCENCE OF THIS DISEASE IS THEREFORE RECORDED AND IMPOSED TO PUT
AS SOON AS POSSIBLE, AT THE DISPOSAL OF A MANUFACTURING LAB,
A FORMULA AGAINST KOCH BACILLES BASED ON NATURAL PRODUCTS, WITHOUT
RISKS OF IATROGENIC EFFECTS.

CETTE FORMULE A ETE CONCUE A BASE D'HUILES ESSENTIELLES DONT CHACUNE A
SES VERTUS PROPRES, PHARMACODYNAMIQUEMENT PARLANT, MAIS DONT LE MELANGE
PRESENTE UNE SYNERGIE PERMETTANT UNE REPONSE CONTRE L'AFFECTION PAR LE
BACILLE DE KOCH.THIS FORMULA HAS BEEN DESIGNED BASED ON ESSENTIAL OILS OF WHICH EACH
ITS OWN VIRTUES, PHARMACODYNAMICALLY TALKING, BUT OF WHICH THE MIXTURE
PRESENTS A SYNERGY ALLOWING A RESPONSE AGAINST AFFECTION BY
BACILLE DE KOCH.

LA PRESENTE INVENTION VISE AINSI A FOURNIR DES MOYENS NON ENCORE UTILISES
A CE JOUR, SUR UNE GRANDE ECHELLE, MAIS OFFRANT TOUTES LES QUALITES D'UN
TRAITEMENT DE CHOIX DANS LA LUTTE CONTRE LA TUBERCULOSE.THE PRESENT INVENTION ALSO AIMS AT PROVIDING MEANS NOT YET USED
TO DATE, ON A LARGE SCALE, BUT OFFERING ALL THE QUALITIES OF A
TREATMENT OF CHOICE IN THE FIGHT AGAINST TUBERCULOSIS.

L'INVENTION SE RESUME, DE FACON GENERALE, EN UN MELANGE D'HUILES ESSEN
TIELLES DONT LES POURCENTAGES VARIENT ENTRE 5,70% ET 44%-DE CHACUN DES
COMPOSANTS : EUCALYPTUS GLOBULUS, MELALEUCA LEUCADENDRON, THYMUS VULGARIS,
HUMULUS LUPULUS, EUGENIA CARYOPHYLATA, MENTHA PIPERITA ET ORIGANUM VULGARE.THE INVENTION CAN BE SUMMARIZED, IN GENERAL, INTO A MIXTURE OF ESSEN OILS
THOSE OF WHICH THE PERCENTAGES VARY BETWEEN 5.70% AND 44% - OF EACH
COMPONENTS: EUCALYPTUS GLOBULUS, MELALEUCA LEUCADENDRON, THYMUS VULGARIS,
HUMULUS LUPULUS, EUGENIA CARYOPHYLATA, MENTHA PIPERITA AND ORIGANUM VULGARE.

EN D'AUTRES TERMES, L'INVENTION A POUR OBJET UN ANTI-BACILLE PUISSANT CON
TRE LE BACILLE DE KOCH.IN OTHER TERMS, THE INVENTION OBJECTS A POWERFUL ANTI-BACILLA
TRE BACILLE DE KOCH.

LA PRESENTE INVENTION NE FAIT PAS INTERVENIR D'AUTRES COMPOSANTS.THIS INVENTION DOES NOT INVOLVE OTHER COMPONENTS.

LA SEULE FORMULATION CI-DESSUS DONNE D'EXCELLENTS RESULTATS DANS LE TRAI
TEMENT DE LA TUBERCULOSE. THE ONLY FORMULATION ABOVE PROVIDES EXCELLENT RESULTS IN THE TRAI
TENT OF TUBERCULOSIS.

Claims (2)

REVENDICATIONS 1) LA FORMULATION CONTRE LA TUBERCULOSE (BACILLE DE KOCH) EST CARACTERISEE1) THE FORMULATION AGAINST TUBERCULOSIS (BACILLE DE KOCH) IS CHARACTERIZED EN CE QU'ELLE CONTIENT SEPT HUILES ESSENTIELLES. IN THAT IT CONTAINS SEVEN ESSENTIAL OILS. 2) FORMULATION SELON LA REVENDICATION 1 CARACTERISEE EN CE QUE LE MELANGE2) FORMULATION ACCORDING TO CLAIM 1 CHARACTERIZED IN THAT THE MIXTURE COMPREND DES HUILES ESSENTIELLES DONT LES POURCENTAGES VARIENT ENTRE INCLUDES ESSENTIAL OILS WHICH PERCENTAGES VARY BETWEEN 5,70% ET 44% DE CHACUN DES COMPOSANTS SUIVANTS: 5.70% AND 44% OF EACH OF THE FOLLOWING COMPONENTS: - EUCALYPTUS GLOBULUS, MELALEUCA LEUCADENDRON, THYMUS VUL - EUCALYPTUS GLOBULUS, MELALEUCA LEUCADENDRON, THYMUS VUL GARIS, HUMULUS LUPULUS, EUGENIA CARYOPHYLATA, MENTHA PIPERITA ET ORI GARIS, HUMULUS LUPULUS, EUGENIA CARYOPHYLATA, MENTHA PIPERITA AND ORI GANUM VULGARE.  GANUM VULGARE.
FR9307804A 1993-06-21 1993-06-21 Formula for the treatment of tuberculosis. Granted FR2706770A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9307804A FR2706770A1 (en) 1993-06-21 1993-06-21 Formula for the treatment of tuberculosis.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9307804A FR2706770A1 (en) 1993-06-21 1993-06-21 Formula for the treatment of tuberculosis.

Publications (2)

Publication Number Publication Date
FR2706770A1 true FR2706770A1 (en) 1994-12-30
FR2706770B1 FR2706770B1 (en) 1995-12-01

Family

ID=9448593

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9307804A Granted FR2706770A1 (en) 1993-06-21 1993-06-21 Formula for the treatment of tuberculosis.

Country Status (1)

Country Link
FR (1) FR2706770A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002451B (en) * 1995-06-29 1996-10-14 ������ �. Anti-inflamatory compositions containing herbal-based active ingredients, methods of preparing same and uses of same for medical and veterinary purposes.
WO1996037210A2 (en) * 1995-05-26 1996-11-28 Ropapharm B.V. I.O. Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
WO1997007812A1 (en) * 1995-08-25 1997-03-06 Jasna Mandic Production process of the ecological pharmaceutical compositions in the veterinary medical field
WO1998056395A1 (en) * 1997-06-12 1998-12-17 Antonio Sacchetti Natural broad-spectrum antibiotic
WO1999027793A2 (en) * 1997-11-28 1999-06-10 Barrier Biotech Limited An antimicrobial composition
WO1999038521A1 (en) * 1998-02-02 1999-08-05 Boehringer Ingelheim Vetmedica Gmbh The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US7411005B2 (en) 2002-02-13 2008-08-12 Van Beek Natural Science, Llc Compositions and methods for increasing milk production in animals

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (en) * 1984-04-18 1985-10-25 Truc Daniel Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it
SU1572637A1 (en) * 1987-06-17 1990-06-23 Научно-Исследовательский Институт Туберкулеза Им.Ш.А.Алимова Medicinal agent for prevention side effect of antituberculous preparations
JPH04149135A (en) * 1990-10-09 1992-05-22 Kureha Chem Ind Co Ltd Perfume composition and perfume product therefrom

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563109A1 (en) * 1984-04-18 1985-10-25 Truc Daniel Phytotherapeutic composition composed of plants containing oils, plants containing mineral salts, plants containing waxes, oxidases and mineral salts, which treats diseases of the airways, and process for preparing it
SU1572637A1 (en) * 1987-06-17 1990-06-23 Научно-Исследовательский Институт Туберкулеза Им.Ш.А.Алимова Medicinal agent for prevention side effect of antituberculous preparations
JPH04149135A (en) * 1990-10-09 1992-05-22 Kureha Chem Ind Co Ltd Perfume composition and perfume product therefrom

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CD-ROM VIDAL, O.V.P. - EDITIONS DU VIDAL, 1992, PARIS *
DATABASE WPI Section Ch Week 9107, Derwent World Patents Index; Class B04, AN 91-050090 *
DATABASE WPI Section Ch Week 9227, Derwent World Patents Index; Class B04, AN 92-223430 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996037210A2 (en) * 1995-05-26 1996-11-28 Ropapharm B.V. I.O. Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
WO1996037210A3 (en) * 1995-05-26 1997-02-06 Ropapharm B V I O Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
GR1002451B (en) * 1995-06-29 1996-10-14 ������ �. Anti-inflamatory compositions containing herbal-based active ingredients, methods of preparing same and uses of same for medical and veterinary purposes.
WO1997001348A1 (en) * 1995-06-29 1997-01-16 Nitsas Fotios A Pharmaceutical compositions containing herbal-based active ingredients; method for preparing same and uses of same for medical and veterinary purposes
WO1997007812A1 (en) * 1995-08-25 1997-03-06 Jasna Mandic Production process of the ecological pharmaceutical compositions in the veterinary medical field
WO1998056395A1 (en) * 1997-06-12 1998-12-17 Antonio Sacchetti Natural broad-spectrum antibiotic
WO1999027793A2 (en) * 1997-11-28 1999-06-10 Barrier Biotech Limited An antimicrobial composition
WO1999027793A3 (en) * 1997-11-28 1999-07-22 Barrier Biotech Limited An antimicrobial composition
WO1999038521A1 (en) * 1998-02-02 1999-08-05 Boehringer Ingelheim Vetmedica Gmbh The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6649660B2 (en) 1999-09-01 2003-11-18 Van Beek Global/Ninkov L.L.C. Composition for treatment of infections of humans and animals
US7411005B2 (en) 2002-02-13 2008-08-12 Van Beek Natural Science, Llc Compositions and methods for increasing milk production in animals

Also Published As

Publication number Publication date
FR2706770B1 (en) 1995-12-01

Similar Documents

Publication Publication Date Title
FR2706770A1 (en) Formula for the treatment of tuberculosis.
Jagtap et al. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases
Liu et al. Antioxidative and free radical scavenging activities of selected medicinal herbs
Pilisuk et al. Fear of technological hazards: One concern or many?
Boyland et al. Carcinogenicity of 2-naphthylhydroxylamine and 2-naphthylamine
Ralebona et al. Effects of ethanolic extract of Garcinia kola on sexual behaviour and sperm parameters in male Wistar rats
BR9914606A (en) Use of dialkyl fumarates
ES2142781T3 (en) VEGETABLE POMADA.
CA2473874A1 (en) A composition for treating neurocerebrovascular disorders
CA2546959A1 (en) Composition of herbal extracts for the treatment of atopic dermatitis, skin allergic conditions and acne
CA2427817A1 (en) Estrone-derivatives having cytoprotective activity
GB0012362D0 (en) Chemical compounds
WO2006125178A3 (en) Tricyclic pyridazine compounds and their uses as therapeutic agents
Kim et al. Inhibitory effect of Poncirus trifoliate on acetylcholinesterase and attenuating activity against trimethyltin-induced learning and memory impairment
Dam Practical aspects of oxcarbazepine treatment
EP1003537B1 (en) Composition comprising propolis and at least an essential oil
FR2715848A1 (en) Topical emulsion for acne, eczema and allergies
NO20071231L (en) New applications of 2-phenyl-substituted imidazotriazine derivatives
AbouZid et al. Antioxidant activity of wild plants collected in Beni-Sueif governorate, Upper Egypt.
Uboh et al. Effect of Costus afer Leaves' Juice on Nitrocellulose Thinner Induced Nephrotoxicity in Rats
Ravindran et al. Chronic anxiolytic-like activity of aqueous extract of Coriandrum sativum seeds using elevated plus maze test in Swiss albino mice
Farra-Haddad Interreligious dialogue: trees, stones, water, and interfaith ritual experiences in Lebanon.
Schempp et al. Comparison of the inhibition of myeloperoxidase-catalyzed hypochlorite formation in vitro and in whole blood by different plant extracts contained in a phytopharmacon treating functional dyspepsia
Lecker Banu Qurayz.
Brown et al. Herpes is common in Mexico

Legal Events

Date Code Title Description
ST Notification of lapse